Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice

Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice

Prostate cancer (PC) is one of the most pressing problems of modern oncology due to high worldwide morbidity for this pathology. Annually, more than 1,100,000 new cases of PC are diagnosed worldwide. The main treatment method for patients with locally advanced and/or metastatic PC is hormone therapy...

Full description

Bibliographic Details
Main Authors: B. Ya. Alekseev, K. M. Nyushko, A. D. Kaprin
Format: Article
Language:Russian
Published: ABV-press 2019-04-01
Series:Onkourologiâ
Subjects:
castration-resistant prostate cancer
chemotherapy
cabazitaxel
docetaxel
proselica trial
firstana trial
clinical case
Online Access:https://oncourology.abvpress.ru/oncur/article/view/933

Internet

https://oncourology.abvpress.ru/oncur/article/view/933

Similar Items